XML 19 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
CASH FLOW FROM OPERATING ACTIVITIES:    
Loss from continuing operations $ (1,857,306) $ (1,883,572)
Adjustments to reconcile net loss to cash used for operating activities:    
Allowance for doubtful accounts (6,741)
Depreciation 42,996 $ 40,186
Amortization of Intangible Assets 13,606 $ 13,606
Debt discount 92,199
Share and warrant-based compensation for employees and consultants 324,115 $ 207,258
Gain on derivative liabilities (31,142) $ (157,253)
Issuance of common stock for directors’ fees 17,000
Change in assets and liabilities:    
Accounts receivable (2,759,323) $ (341,316)
Due from factor 39,236 (74,208)
Inventory (336,820) $ (2,449)
Software license rights (12,000,000)
Prepaid expenses and other 139,226 $ (162,947)
Accounts payable 811,244 (193,601)
Accrued liabilities 4,450 150,296
Deferred revenue (52,828) (98,927)
Net cash used for operating activities (15,560,088) (2,502,927)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (3,364) (18,633)
Net cash used for investing activities (3,364) $ (18,633)
CASH FLOW FROM FINANCING ACTIVITIES:    
Proceeds from Issuance of Convertible Preferred Stock 19,500,000
Proceeds from issuances of common stock   $ 1,595,000
Proceeds from issuance of note payable 250,000
Repayment of note payable $ (250,000)
Repurchase of outstanding warrants $ (150,000)
Costs to issue preferred and common stock and note payable $ (459,102) (103,157)
Net cash provided by financing activities 19,040,898 1,341,843
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 3,477,446 (1,179,717)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 843,632 2,023,349
CASH AND CASH EQUIVALENTS, END OF YEAR 4,321,078 $ 843,632
Cash paid for:    
Interest $ 100,000
Noncash investing and financing activities:    
Reclassification of derivative liability to additional paid-in capital $ 42,597
Issuance of warrants for financing raise $ 92,199  
Dividends payable – preferred stock $ 133,851 $ 3,435